Reactive oxygen species and insulin resistance: the good, the bad and the ugly

被引:193
|
作者
Tiganis, Tony [1 ]
机构
[1] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia
基金
英国医学研究理事会;
关键词
TUMOR-NECROSIS-FACTOR; PROTEIN-TYROSINE PHOSPHATASES; ENDOPLASMIC-RETICULUM STRESS; OXIDATIVE STRESS; SKELETAL-MUSCLE; REVERSIBLE OXIDATION; UNITED-STATES; VITAMIN-E; LIPID-PEROXIDATION; FACTOR RECEPTOR;
D O I
10.1016/j.tips.2010.11.006
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Reactive oxygen species (ROS) contribute to the progression of various human diseases, including type 2 diabetes mellitus (T2DM). ROS can suppress the insulin response and contribute to the development of insulin resistance, a key pathological feature of T2DM. Paradoxically, ROS generated by NADP(H) oxidases at the plasma membrane and endomembranes might also be required for normal intracellular signaling. Growth factors, cytokines and hormones such as insulin promote the generation of ROS for the coordinated inactivation of protein tyrosine phosphatases and the promotion of tyrosine phosphorylation-dependent signaling. A recent study has established the potential of H2O2 to enhance insulin sensitivity in vivo and attenuate the development of insulin resistance. Thus, ROS have the capacity to both promote and attenuate the insulin response. Here I review evidence indicating that ROS promote insulin sensitivity versus insulin resistance and discuss the potential complications associated with the widespread use of antioxidants.
引用
收藏
页码:82 / 89
页数:8
相关论文
共 50 条
  • [1] Insulin resistance - "the good or the bad and ugly"
    Szosland, Konrad
    Lewinski, Andrzej
    [J]. NEUROENDOCRINOLOGY LETTERS, 2018, 39 (05) : 355 - 362
  • [2] Biological and physiological role of reactive oxygen species - the good, the bad and the ugly
    Zuo, L.
    Zhou, T.
    Pannell, B. K.
    Ziegler, A. C.
    Best, T. M.
    [J]. ACTA PHYSIOLOGICA, 2015, 214 (03) : 329 - 348
  • [3] Reactive oxygen species: The good, the bad, and the enigma
    Ogrunc, Muge
    [J]. MOLECULAR & CELLULAR ONCOLOGY, 2014, 1 (03):
  • [4] Antimicrobial resistance: the good, the bad, and the ugly
    Hardie, Kim R.
    [J]. EMERGING TOPICS IN LIFE SCIENCES, 2020, 4 (02) : 129 - 136
  • [5] Multidrug resistance: overcoming the good, the bad, and the ugly
    Rund, Deborah
    [J]. LEUKEMIA & LYMPHOMA, 2010, 51 (10) : 1771 - 1772
  • [6] The good, the bad, and the ugly, but how ugly is ugly?
    Bauer, Andreas
    Leucker, Martin
    Schallhart, Christian
    [J]. RUNTIME VERIFICATION, 2007, 4839 : 126 - +
  • [7] Good, Bad, Ugly
    Rouhi, A. Maureen
    [J]. CHEMICAL & ENGINEERING NEWS, 2013, 91 (06) : 3 - 3
  • [8] The good, the bad and the ugly
    McCann, Shaun
    [J]. BONE MARROW TRANSPLANTATION, 2018, 53 (09) : 1087 - 1088
  • [9] The good, the bad, and the ugly
    Jones, WE
    [J]. JOURNAL OF EQUINE VETERINARY SCIENCE, 1996, 16 (02) : 45 - 45
  • [10] The good, the bad, and the ugly
    Bromund, TR
    [J]. FOREIGN AFFAIRS, 2000, 79 (05) : 155 - 156